Quitting Smoking With COPD: What Works
SaveQuitting smoking is the single most important step for anyone with COPD. It slows the accelerated lung function decline that defines the disease, reduces exacerbations, and improves survival — no medication produces comparable benefit. Most people succeed with a combination of pharmacotherapy (varenicline, NRT, or bupropion) and behavioral counseling.
Last updated: July 2026History
Talk to a clinician
A primary-care clinician
Gale can help you find one in your state and request a visit.
Find care →Does quitting smoking actually help if I already have COPD?
Yes — substantially. Smoking causes COPD by destroying air sacs and scarring the airways, and continuing to smoke accelerates that destruction at a rate far beyond normal aging. Quitting smoking does not restore the lung tissue already lost, but it dramatically slows the rate of further decline 1Ref 1Global Initiative for Chronic Obstructive Lung Disease (2024).Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2024 Report).Smoking cessation as the most effective intervention for slowing COPD progression, with benefit at all stages.
Studies of people who quit with COPD show: - The steep decline in FEV1 (a key breathing measurement) slows to nearly the same rate as non-smokers - Exacerbation frequency tends to decrease - Quality of life improves - Survival is extended
These benefits are real at any stage of COPD — even severe disease. There is no stage at which it is "too late" to benefit from quitting [1,2].
Why is quitting smoking particularly hard with COPD?
People with COPD typically have a long, heavy smoking history — which correlates with stronger physical and psychological dependence on nicotine. They may also experience higher rates of depression and anxiety, which are common with COPD and make quitting harder 2Ref 2Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. (2023).Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.Depression, anxiety, and nicotine dependence as barriers to cessation in COPD; benefits of smoking cessation on exacerbation rates. Some people also worry, incorrectly, that the quit-aid medications are unsafe for someone with lung disease.
This is why the most effective approach combines medication and behavioral support — neither alone is as powerful as both together [3,4].
What medications help people with COPD quit smoking?
Nicotine Replacement Therapy (NRT)
NRT replaces some of the nicotine from cigarettes to reduce withdrawal symptoms without the harmful combustion products. Forms include the patch (slow, steady release), gum, lozenge, inhaler, and nasal spray 4Ref 4National Cancer Institute / HHS (2023).Using Nicotine Replacement Therapy.Forms of NRT available (patch, gum, lozenge, inhaler, nasal spray) and patient guidance on use. Combination NRT — patch plus a fast-acting form such as gum or lozenge — is more effective than a single form alone 3Ref 3Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T (2018).Nicotine Replacement Therapy versus Control for Smoking Cessation.NRT effectiveness for smoking cessation; combination NRT superior to single-form NRT.
NRT is safe for people with COPD and cardiovascular disease. There is no evidence that NRT at standard doses harms people with heart or lung disease.
Varenicline (Chantix)
Varenicline is the most effective single medication for smoking cessation 5Ref 5Livingstone-Banks J, Fanshawe TR, Thomas KH, et al. (2023).Nicotine Receptor Partial Agonists for Smoking Cessation.Varenicline as the most effective single pharmacotherapy for smoking cessation. It works by partially activating nicotine receptors in the brain, reducing withdrawal cravings and blocking the reward effect of cigarettes. The large EAGLES trial demonstrated that varenicline was safe and effective even in people with serious psychiatric conditions, which addressed earlier concerns 6Ref 6Anthenelli RM, Benowitz NL, West R, et al. (2016).Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers with and without Psychiatric Disorders (EAGLES): A Double-Blind, Randomised, Placebo-Controlled Clinical Trial.Safety and efficacy of varenicline and bupropion confirmed in the EAGLES trial including in people with psychiatric conditions.
Varenicline requires a prescription. It is taken for 12 weeks and is frequently extended for an additional 12 weeks to consolidate abstinence.
Bupropion (Zyban/Wellbutrin)
Bupropion is an antidepressant that also reduces nicotine cravings and withdrawal by acting on dopamine pathways. It is effective and an option when varenicline is not tolerated or contraindicated. The EAGLES trial confirmed its safety profile comparable to NRT 6Ref 6Anthenelli RM, Benowitz NL, West R, et al. (2016).Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers with and without Psychiatric Disorders (EAGLES): A Double-Blind, Randomised, Placebo-Controlled Clinical Trial.Safety and efficacy of varenicline and bupropion confirmed in the EAGLES trial including in people with psychiatric conditions.
What behavioral support is most effective?
The USPSTF recommends that clinicians offer behavioral counseling to all adults who use tobacco — in combination with medication, this is the highest-value approach 7Ref 7US Preventive Services Task Force (2021).Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement.USPSTF recommendation for combining behavioral counseling with medication as the highest-value cessation approach.
Effective strategies include: - Setting a specific quit date — commit to a date within the next two weeks - Identifying triggers — stress, alcohol, coffee, certain social situations — and planning alternatives - Quitlines — telephone-based counseling services (such as 1-800-QUIT-NOW in the US) provide multiple sessions of free support - Text-based programs — SmokefreeTXT and similar services offer real-time motivational messages - In-person or group support — especially helpful for people with a long history and previous failed attempts - Pulmonary rehabilitation — structured exercise and education programs for COPD typically integrate smoking cessation support
Combined medication plus counseling roughly doubles quit rates compared to medication alone.
What happens to my lungs after I quit?
The health timeline for quitting is real and begins quickly 8Ref 8Centers for Disease Control and Prevention (2023).Benefits of Quitting Smoking.Timeline of health benefits after quitting smoking including cardiovascular and pulmonary recovery:
- Within 20 minutes: blood pressure and heart rate begin to normalize
- Within 12–24 hours: carbon monoxide clears from the blood; oxygen delivery improves
- Within weeks: cough and mucus production often decrease as the airways begin to clear
- Within months to a year: lung function typically stabilizes rather than continuing to drop
- Over years: risk of lung infection, heart attack, and stroke decreases; the rate of COPD progression slows substantially
For people with COPD who also qualify for annual lung cancer screening — a low-dose CT scan recommended by the USPSTF for long-term heavy smokers aged 50–80 — quitting also reduces the lung cancer risk that screening aims to catch 9Ref 9Krist AH, Davidson KW, Mangione CM, et al. (US Preventive Services Task Force) (2021).Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.Annual low-dose CT screening eligibility for long-term heavy smokers and former smokers with COPD risk.
How can a Gale clinician help me quit?
A Gale primary care clinician can:
- Assess your smoking history and nicotine dependence level
- Prescribe varenicline, bupropion, or combination NRT
- Connect you with quitline counseling and digital support tools
- Monitor your COPD symptoms as you quit — some people notice temporary changes in cough or mucus as the airways clear
- Adjust your COPD inhalers as needed now that you are not smoking
- Check whether you are eligible for lung cancer screening
Most people need multiple attempts before quitting permanently — this is not a sign of weakness. Each attempt is a learning experience, and the chances of success increase with the right combination of medication and support.
Common questions
Related
Lungs & breathing
Can Smoking Lung Damage Be Reversed After Quitting?Lungs & breathing
Pulmonary Fibrosis Prognosis: IPF Life Expectancy and ProgressionLungs & breathing
Pulmonary Function Test (PFT): What to Expect and What Results Mean
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
Talk to a clinician
A primary-care clinician
Gale can help you find one in your state and request a visit.
Find care →Important notes for COPD and quitting
- —Worsening breathlessness, increased sputum, or a change in sputum color after quitting — these can signal a COPD exacerbation that needs treatment
- —Mood changes or unusual thoughts after starting varenicline or bupropion — contact your clinician promptly
- —Severe breathlessness at rest or coughing up blood — seek emergency care
Call 911 or go to the emergency room for severe breathing difficulty that is not relieved by your rescue inhaler.
This article is educational and does not replace a clinical evaluation or prescription guidance from your clinician. Smoking cessation medications require individual assessment. Work with your Gale primary care clinician to choose the approach that is right for your history and health.
Did this answer your question?
References
- 1.Global Initiative for Chronic Obstructive Lung Disease (2024). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2024 Report). Global Initiative for Chronic Obstructive Lung Disease. link ✓Smoking cessation as the most effective intervention for slowing COPD progression, with benefit at all stages
- 2.Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. (2023). Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. American Journal of Respiratory and Critical Care Medicine. doi:10.1164/rccm.202301-0106PP ✓Depression, anxiety, and nicotine dependence as barriers to cessation in COPD; benefits of smoking cessation on exacerbation rates
- 3.Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T (2018). Nicotine Replacement Therapy versus Control for Smoking Cessation. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD000146.pub5 ✓NRT effectiveness for smoking cessation; combination NRT superior to single-form NRT
- 4.National Cancer Institute / HHS (2023). Using Nicotine Replacement Therapy. Smokefree.gov. link ✓Forms of NRT available (patch, gum, lozenge, inhaler, nasal spray) and patient guidance on use
- 5.Livingstone-Banks J, Fanshawe TR, Thomas KH, et al. (2023). Nicotine Receptor Partial Agonists for Smoking Cessation. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD006103.pub9 ✓Varenicline as the most effective single pharmacotherapy for smoking cessation
- 6.Anthenelli RM, Benowitz NL, West R, et al. (2016). Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers with and without Psychiatric Disorders (EAGLES): A Double-Blind, Randomised, Placebo-Controlled Clinical Trial. Lancet. doi:10.1016/S0140-6736(16)30272-0 ✓Safety and efficacy of varenicline and bupropion confirmed in the EAGLES trial including in people with psychiatric conditions
- 7.US Preventive Services Task Force (2021). Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. JAMA. doi:10.1001/jama.2020.25019 ✓USPSTF recommendation for combining behavioral counseling with medication as the highest-value cessation approach
- 8.Centers for Disease Control and Prevention (2023). Benefits of Quitting Smoking. CDC Smoking and Tobacco Use. link ✓Timeline of health benefits after quitting smoking including cardiovascular and pulmonary recovery
- 9.Krist AH, Davidson KW, Mangione CM, et al. (US Preventive Services Task Force) (2021). Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. doi:10.1001/jama.2021.1117 ✓Annual low-dose CT screening eligibility for long-term heavy smokers and former smokers with COPD risk
9 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy